PDF herunterladen
Semin Thromb Hemost 2007; 33(1): 075-079
DOI: 10.1055/s-2006-958465
Copyright © 2007 by Thieme Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Prostasomes, Angiogenesis, and Tissue Factor

George H. Delves1 , Alistair B. Stewart2 , Alan J. Cooper1 , Bashir A. Lwaleed3
  • 1School of Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
  • 2Pyrah Department of Urology, St. James' University Hospital Leeds, Leeds, United Kingdom
  • 3Department of Urology, Southampton University Hospitals NHS Trust, Southampton, United Kingdom
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
29. Januar 2007 (online)

    Lizenzen und Reprints

ABSTRACT

Prostasomes are membrane-bound secretory vesicles produced by prostatic epithelial cells. They are known to carry many proteins, including tissue factor, and have membranes unusually rich in cholesterol and sphingomyelin. Prostasomes have well-documented effects on fertility, promoting sperm motility, stabilizing the acrosome reaction, and facilitating immunosuppression. This article reviews the evidence of the effects of prostasomes on in vitro angiogenesis assays, and the mechanism by which these effects occur. Seminal prostasomes seem to inhibit angiogenesis, whereas the equivalent particles released by malignant prostate cells promote angiogenesis. In both cases, the effects seem preserved after heat treatment to denature the protein content, suggesting an important role for lipid transfer, in particular, transfer of sphingomyelin.

KEYWORDS

Prostasomes - angiogenesis - sphingomyelin - tissue factor

REFERENCES

  • 1 Ronquist G, Hedström M. Restoration of detergent-inactivated adenosine triphosphatase activity of human prostatic fluid with concanavalin A.  Biochim Biophys Acta. 1977;  483 483-486
    PubMedGoogle Scholar
  • 2 Ronquist G, Brody I, Gottfries A, Stegmayr B A. Mg2 + and Ca2 + -stimulated adenosine triphosphatase in human prostatic fluid.  Andrologia. 1978;  10 261-272 (part I), 427-433 (part II)
    PubMedGoogle Scholar
  • 3 Ronquist G, Brody I. The prostasome: its secretion and function in man.  Biochim Biophys Acta. 1985;  822 203-218
    PubMedGoogle Scholar
  • 4 Arienti G, Carlini E, Saccardi C, Palmerini C A. Fatty acid pattern of human prostasome lipid.  Arch Biochem Biophys. 1998;  358 391-395
    CrossrefPubMedGoogle Scholar
  • 5 Arienti G, Saccardi C, Carlini E, Verdacchi R, Palmerini C A. Distribution of lipid and protein in human semen fractions.  Clin Chim Acta. 1999;  289 111-120
    CrossrefPubMedGoogle Scholar
  • 6 Kelly R W, Holland P, Skibinski G et al.. Extracellular organelles (prostasomes) are immunosuppressive components of human semen.  Clin Exp Immunol. 1991;  86 550-556
    PubMedGoogle Scholar
  • 7 Carlini E, Palmerini A, Cosmi E V, Arienti G. Fusion of sperm with prostasomes: effects on membrane fluidity.  Arch Biochem Biophys. 1997;  343 6-12
    CrossrefPubMedGoogle Scholar
  • 8 Saez F, Motta C, Boucher D, Grizard G. Prostasomes inhibit the NADPH oxidase activity of human neutrophils.  Mol Hum Reprod. 2000;  6 883-891
    CrossrefPubMedGoogle Scholar
  • 9 Utleg A G, Yi E C, Xie T et al.. Proteomic analysis of human prostasomes.  Prostate. 2003;  56 150-161
    CrossrefPubMedGoogle Scholar
  • 10 Arienti G, Carlini E, Nicolucci A, Cosmi E V, Santi F, Palmerini C A. The motility of human spermatozoa as influenced by prostasomes at various pH levels.  Biol Cell. 1999;  91 51-54
    CrossrefPubMedGoogle Scholar
  • 11 Palmerini C A, Saccardi C, Carlini E, Fabiani R, Arienti G. Fusion of prostasomes to human spermatozoa stimulates the acrosome reaction.  Fertil Steril. 2003;  80 1181-1184
    CrossrefPubMedGoogle Scholar
  • 12 Fernández J A, Heeb M J, Radtke K P, Griffin J H. Potent blood coagulant activity of human semen due to prostasome-bound tissue factor.  Biol Reprod. 1997;  56 757-763
    CrossrefPubMedGoogle Scholar
  • 13 Stewart A B, Anderson W, Delves G, Lwaleed B A, Birch B, Cooper A. Prostasomes: a role in prostatic disease?.  BJU Int. 2004;  94 985-989
    CrossrefPubMedGoogle Scholar
  • 14 Ronquist G, Nilsson B O. The Janus-faced nature of prostasomes: their pluripotency favours the normal reproductive process and malignant prostate growth.  Prostate Cancer Prostatic Dis. 2004;  7 21-31
    CrossrefPubMedGoogle Scholar
  • 15 Hanahan D, Weinberg R A. The hallmarks of cancer.  Cell. 2000;  100 57-70
    CrossrefPubMedGoogle Scholar
  • 16 Tannock I F. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour.  Br J Cancer. 1968;  22 258-273
    PubMedGoogle Scholar
  • 17 Hepburn P J, Griffiths K, Harper M E. Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro.  Prostate. 1997;  33 123-132
    CrossrefPubMedGoogle Scholar
  • 18 Weingartner K, Ben-Sasson S A, Stewart R, Richie J P, Riedmiller H, Folkman J. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: an in vitro model for assessment.  J Urol. 1998;  159 465-470
    CrossrefPubMedGoogle Scholar
  • 19 Joseph I B, Nelson J B, Denmeade S R, Isaacs J T. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.  Clin Cancer Res. 1997;  3 2507-2511
    PubMedGoogle Scholar
  • 20 Levine A C, Liu X H, Greenberg P D et al.. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts.  Endocrinology. 1998;  139 4672-4678
    CrossrefPubMedGoogle Scholar
  • 21 Zhong H, De Marzo A M, Laughner E et al.. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.  Cancer Res. 1999;  59 5830-5835
    PubMedGoogle Scholar
  • 22 Fortier A H, Nelson B J, Grella D K, Holaday J W. Antiangiogenic activity of prostate-specific antigen.  J Natl Cancer Inst. 1999;  91 1635-1640
    CrossrefPubMedGoogle Scholar
  • 23 Heidtmann H H, Nettelbeck D M, Mingels A, Jager R, Welker H G, Kontermann R E. Generation of angiostatin-like fragments from plasminogen by prostate specific antigen.  Br J Cancer. 1999;  81 1269-1273
    CrossrefPubMedGoogle Scholar
  • 24 Weidner N, Carroll P R, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.  Am J Pathol. 1993;  143 401-409
    PubMedGoogle Scholar
  • 25 Fregene T A, Khanuja P S, Noto A C et al.. Tumor-associated angiogenesis in prostate cancer.  Anticancer Res. 1993;  13 2377-2382
    PubMedGoogle Scholar
  • 26 Borre M, Offersen B V, Nerstrom B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting.  Br J Cancer. 1998;  78 940-944
    PubMedGoogle Scholar
  • 27 Brawer M K, Deering R E, Brown M, Preston S D, Bigler S A. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity.  Cancer. 1994;  73 678-687
    CrossrefPubMedGoogle Scholar
  • 28 Silberman M A, Partin A W, Veltri R W, Epstein J I. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.  Cancer. 1997;  79 772-779
    CrossrefPubMedGoogle Scholar
  • 29 Strohmeyer D, Rossing C, Strauss F, Bauerfeind A, Kaufmann O, Loening S. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.  Prostate. 2000;  42 26-33
    CrossrefPubMedGoogle Scholar
  • 30 Vartanian R K, Weidner N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.  Lab Invest. 1995;  73 844-850
    PubMedGoogle Scholar
  • 31 Abdulkadir S A, Carvalhal G F, Kaleem Z et al.. Tissue factor expression and angiogenesis in human prostate carcinoma.  Hum Pathol. 2000;  31 443-447
    CrossrefPubMedGoogle Scholar
  • 32 Versteeg H H, Peppelenbosch M P, Spek C A. Tissue factor signal transduction in angiogenesis.  Carcinogenesis. 2003;  24 1009-1013
    CrossrefPubMedGoogle Scholar
  • 33 Bugge T H, Xiao Q, Kombrinck K W et al.. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.  Proc Natl Acad Sci U S A. 1996;  93 6258-6261
    CrossrefPubMedGoogle Scholar
  • 34 Toomey J R, Kratzer K E, Lasky N M, Stanton J J, Broze Jr G J. Targeted disruption of the murine tissue factor gene results ion embryonic lethality.  Blood. 1996;  88 1583-1587
    PubMedGoogle Scholar
  • 35 Rosen E D, Chan J C, Idusogie E et al.. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding.  Nature. 1997;  390 290-294
    CrossrefPubMedGoogle Scholar
  • 36 Rosen E D, Zhong L, Cornelissen I, Martin A, Castellino F J. Coagulation factor VII is required for embryonic development in mice.  Blood. 2001;  98 3424(Abst)
    PubMedGoogle Scholar
  • 37 Koomagi R, Volm M. Tissue-factor expression in human nonsmall-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis.  Int J Cancer. 1998;  79 19-22
    CrossrefPubMedGoogle Scholar
  • 38 Takano S, Tsuboi K, Tomono Y, Mitsui Y, Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression.  Br J Cancer. 2000;  82 1967-1973
    CrossrefPubMedGoogle Scholar
  • 39 Shoji M, Hancock W W, Abe K et al.. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.  Am J Pathol. 1998;  152 399-411
    PubMedGoogle Scholar
  • 40 Zhang Y, Deng Y, Luther T et al.. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.  J Clin Invest. 1994;  94 1320-1327
    Google Scholar
  • 41 Hicks J A, Anderson W M, Lwaleed B A, Cooper A J, Holmes S AV. Do CD142 carrying prostatic exosomes promote angiogenesis?.  BJU Int. 2005;  95(suppl 5) 81(Abst)
    PubMedGoogle Scholar
  • 42 Delves G H, Stewart A B, Lwaleed B A, Cooper A J. In vitro inhibition of angiogenesis by prostasomes.  Prostate Cancer Prostatic Dis. 2005;  8 174-178
    CrossrefPubMedGoogle Scholar
  • 43 Arienti G, Polci A, Carlini E, Palmerini C A. Transfer of CD26/dipeptidyl peptidase (E.C.3.5.4.4.) from prostasomes to sperm.  FEBS Lett. 1997;  410 343-346
    CrossrefPubMedGoogle Scholar
  • 44 Arienti G, Carlini E, Verdacchi R, Palmerini C A. Transfer of aminopeptidase activity from prostasomes to sperm.  Biochim Biophys Acta. 1997;  1336 269-274
    PubMedGoogle Scholar
  • 45 Delves G H, Goyal A, Lwaleed B A, Cooper A J. Seminal prostasomes inhibit the angiogenesis activity of rat aortic rings.  Prostate Cancer Prostatic Dis. 2006;  9(4) 444-447
    CrossrefPubMedGoogle Scholar
  • 46 Kim C W, Lee H M, Lee T H, Kang C, Kleinman H K, Gho Y S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.  Cancer Res. 2002;  62 6312-6317
    PubMedGoogle Scholar
  • 47 Carlsson L, Nilsson O, Larsson A, Stridsberg M, Sahlen G, Ronquist G. Characteristics of human prostasomes isolated from three different sources.  Prostate. 2003;  54 322-330
    CrossrefPubMedGoogle Scholar
  • 48 Nilsson B O, Lennartsson L, Carlsson L, Nilsson S, Ronquist G. Expression of prostasome-like granules by the prostate cancer cell lines PC3, Du145, and LnCaP grown in monolayer.  Ups J Med Sci. 1999;  104 199-206
    PubMedGoogle Scholar
  • 49 Nilsson B O, Egevard L, Jin M, Ronquist G, Busch C. Distribution of prostasomes in neoplastic epithelial prostate cells.  Prostate. 1999;  39 36-40
    CrossrefPubMedGoogle Scholar
  • 50 Wang J, Lundqvist M, Carlsson L, Nilsson O, Lundkvist O, Ronquist G. Prostasome-like granules from the PC-3 prostate cancer cell line increase the motility of washed human spermatozoa and adhere to the sperm.  Eur J Obstet Gynecol Reprod Biol. 2001;  96 88-97
    CrossrefPubMedGoogle Scholar
  • 51 Abrahamsson P A, Falkmer S, Falt K, Grimelius L. The course of neuroendocrine differentiation in prostatic adenocarcinomas. An immunohistochemical study testing chromogranin A as an “endocrine marker”.  Pathol Res Pract. 1989;  185 373-380
    PubMedGoogle Scholar
  • 52 Schmid K W, Helpap B, Totsch M et al.. Immunohistochemical localization of chromogranins A and B and secretogranin II in normal, hyperplastic, and neoplastic prostate.  Histopathology. 1994;  24 233-239
    PubMedGoogle Scholar
  • 53 Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. Angiogenesis assays: a critical overview.  Clin Chem. 2003;  49 32-40
    CrossrefPubMedGoogle Scholar
  • 54 Matsubara K, Matsumoto H, Mizushina Y et al.. Inhibitory effect of glycolipids from spinach on in vitro and ex vivo angiogenesis.  Oncol Rep. 2005;  14 157-160
    PubMedGoogle Scholar

Dr. Bashir A Lwaleed

Department of Urology, Central Block, E Level, West Wing, Mailpoint 67, Southampton University Hospitals

Southampton, Tremona Road, SO16 6YD, United Kingdom

eMail: bashir@soton.ac.uk

      >